UT Southwestern Medical Center scientists have identified a protein that appears to act as a master control switch for ...

Restrictive versions of high-protein, low-carb diets can do more harm than good. Learn why less restriction and more ...

From vision changes to genetic traffic jams and a clinical trial update, May was full of HD science excitement! Dive into our latest roundup to see how researchers are advancing Huntington’s ...

Charles River and CHDI announce an extension of their partnership, having worked together since 2005 to expedite therapies for Huntington's disease.

AbbVie (NYSE: ABBV) in partnership with the University of Toronto's SpinUp, are pleased to announce Neuropeutics Inc as the ...

Genetic mutations occur everyday in our cells, but the vast majority of them are repaired. New research finds DNA repair is not on PAR in HD cells, causing mutations to build up in people with HD.

Huntington's disease is a genetic disorder that kills nerve cells in the brain, causing people to lose their cognitive and ...

Ten years ago, researchers from the University at Buffalo provided some insight into a long-standing neuroscience conundrum: How precisely does Huntington's disease result from a mutation in the ...

PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced results from the Phase 2 PIVOT-HD study of PTC518 (votoplam) in Stage 2 and Stage 3 Huntington's disease (HD) patients. The study met its primary ...

BUFFALO, N.Y. — A decade ago, University at Buffalo researchers shed some light on an enduring neuroscience mystery: How exactly does a mutated huntingtin protein (HTT) cause Huntington’s disease?

How exactly does a mutated huntingtin protein (HTT) cause Huntington’s disease? They found that HTT is something like a traffic controller inside neurons, moving different cargo along neuronal ...

Discovery of new underlying mechanism opens up possibilities for developing medication, researchers at Chinese University of Hong Kong say.